Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
RESEARCH TOOLSreports
Enanta Pharmaceuticals (ENTA) Ownership Overview
7.27% Insiders
14.75% Mutual Funds
22.71% Other Institutional Investors
11.27% ETFs
43.99% Public Companies and
Individual Investors
The ownership structure of Enanta Pharmaceuticals (ENTA) stock is a mix of institutional, retail, and individual investors. Approximately 48.74% of the company’s stock is owned by Institutional Investors, 7.27% is owned by Insiders, and 43.99% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 12, 2025 | Jay Luly President & Ceo,director | xxxxxxxxxxxxx | $256050 |
| Dec 10, 2024 | Brendan Luu Cbo | xxxxxxxxxxxxx | $18401 |
| Dec 10, 2024 | Tara Lynn Kieffer Chief Product Strategy Officer | xxxxxxxxxxxxx | $18401 |
| Dec 10, 2024 | xxxxxxxxxxxxx | $6980 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,108,262 | Institution | 9.88% | 15,052,991 | |
| 1,088,055 | Institution | 5.10% | 7,768,713 | |
| 967,090 | Institution | 4.53% | 6,905,023 | |
| 911,208 | Institution | 4.27% | 6,506,025 | |
| 864,654 | Insider | 4.05% | 6,173,630 | |
| 481,503 | Institution | 2.26% | 3,437,931 | |
| 374,535 | Insider | 1.76% | 2,674,180 | |
| 274,711 | Institution | 1.29% | 1,961,437 | |
| 223,956 | Institution | 1.05% | 1,599,046 | |
| 205,211 | Institution | 0.96% | 1,465,207 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 911,208 | Institution | 4.27% | 6,506,025 | |
| 481,503 | Institution | 2.26% | 3,437,931 | |
| 274,711 | Institution | 1.29% | 1,961,437 | |
| 223,956 | Institution | 1.05% | 1,599,046 | |
| 205,211 | Institution | 0.96% | 1,465,207 | |
| 119,191 | Institution | 0.56% | 851,024 | |
| 109,595 | Institution | 0.51% | 782,508 | |
| 109,547 | Institution | 0.51% | 782,166 | |
| 95,578 | Institution | 0.45% | 682,427 | |
| 84,628 | Institution | 0.40% | 604,244 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 629,597 | Institution | 2.95% | 3,620,183 | |
| 546,219 | Institution | 2.56% | 3,900,004 | |
| 281,611 | Institution | 1.32% | 1,619,263 | |
| 183,879 | Institution | 0.86% | 1,312,896 | |
| 122,762 | Institution | 0.58% | 876,521 | |
| 95,811 | Institution | 0.45% | 550,913 | |
| 94,261 | Institution | 0.44% | 706,958 | |
| 65,452 | Institution | 0.31% | 376,349 | |
| 57,015 | Institution | 0.27% | 427,613 | |
| 45,316 | Institution | 0.21% | 323,556 |
FAQ
Who Owns Enanta Pharmaceuticals (ENTA)?
According to the latest TipRanks data, approximately 22.71% of the company's stock is held by institutional investors, 7.27% is held by insiders, and 43.99% is held by retail investors.
What percentage of Enanta Pharmaceuticals (ENTA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 22.71% of Enanta Pharmaceuticals (ENTA) stock is held by institutional investors.
What percentage of Enanta Pharmaceuticals (ENTA) stock is held by retail investors?
According to the latest TipRanks data, approximately 43.99% of Enanta Pharmaceuticals (ENTA) stock is held by retail investors.
Who owns the most shares of Enanta Pharmaceuticals (ENTA)?
Andrew J.M. Spokes owns the most shares of Enanta Pharmaceuticals (ENTA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.